期刊文献+

恶性胸膜间皮瘤29例分析 被引量:2

Treatment of Malignant Pleural Mesothelioma and 29 Cases Report
下载PDF
导出
摘要 目的 探讨恶性胸膜间皮瘤诊断和治疗的临床特点。方法 回顾性分析手术治疗 2 9例恶性胸膜间皮瘤患者的临床资料。结果 术后 2年生存率为 5 1.7% (15 / 2 9) ,5年生存率为 3 1.0 % (9/ 2 9)。手术并发症发生率为 2 4.1% (7/ 2 9) ,无手术死亡者。接受根治术、姑息手术、探查术的患者 5年生存率存在明显差异 ;局限型患者 5年生存率高于弥漫型患者。患者生存率与TNM分期明显相关。结论 手术治疗恶性胸膜间皮瘤有效。国际间皮瘤研究组提出的新的恶性胸膜间皮瘤TNM分期标准客观且可行。Ⅰ、Ⅱ期患者适行手术治疗 ;Ⅳ期患者不适行手术治疗 ;对局限型、上皮型。 Objective To investigate the diagnosis and treatment of malignant pleural mesothelioma.Methods From December 1969 to February 1998,29 patients with pathologically confirmed malignant pleural mesothelioma underwent surgical treatment in our hospital.The follow-up period was at least 6 months.Results The overall survival rates were 51.7% at 2 years and 31.0% at 5 years.The operative complication rate was 24.1% without mortality from operation.5-year survival rate was significantly different between patients treated with radical resection,palliative pleurectomy,and exploratory thoracotomy.The patients with local type had a significantly better survival rate(66.7% for 2-year;53.3% for 5-year) than those with diffuse type(33.3% for 2-year, 11.1% for 5-year).The TNM staging system had a close relationship with survival rates.Conclusion Surgical intervention is appropriate treatment for selected patients with malignant pleural mesothelioma.TNM staging system provides an internationally accepted basis for the analysis of survival rates in prospective clinical trials.Pleurectomy/decortication and extrapleural pneumonectomy provide good result for patients with stage Ⅰ or Ⅱ,except those with stage Ⅳ.For patients with stage Ⅲ,radical resection is considerable for those with local type and epithelial histological type.
出处 《实用癌症杂志》 2003年第5期505-507,共3页 The Practical Journal of Cancer
关键词 恶性胸膜间皮瘤 分析 诊断 治疗 外科手术 Malignant Pleural mesothelioma Surgical procedures
  • 相关文献

参考文献12

  • 1Ruffle P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec:a respective study of 332 patients[J]. J Clin Oncol, 1989,7(8):1157.
  • 2Ruseh VW, Piantadose S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma:a lung cancer study group trial[J]. J Thorae Cardiovasc Surg, 1991,102(1 ) : 1.
  • 3From the International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma [J]. Chest, 1995, 108 (4) :122.
  • 4Renshaw AA, Dean RR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma[J ]. Chest, 1997,111 (1) : 106.
  • 5Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1 : diagnosis [ J ]. Cancer, 1993,72 (2) : 389.
  • 6Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural malignant mesothelioma [J]. Chest, 1995,108(3) :754.
  • 7Carella R. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma, a study with logistic regression analysis[J].Am J Shrg Pathol,2001,25(1) :43.
  • 8Byrne ME, Davidson JA, Musk AW, et al. Cisplatin and gemcitabin treatment for malignant mesothelioma: aphase Ⅱ study [ abstract ] [ M ]. Paper present at the 34 Annul Meeting of the American Society of Clinical Oncology, 1998:16-- 19.
  • 9Linden CJ, Meroke C, Albrechtsson U, et al. Effects of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesothelioma:a non-randomized phase Ⅱ study [J ]. Eur Respir J,1996,9(12) :2565.
  • 10Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma[J ]. J Thoracic Cardiovase Surg, 1996,111 (4) : 815.

同被引文献45

  • 1单厚昌,宫玉慧.胸膜间皮瘤诊断和临床治疗的研究进展[J].现代中西医结合杂志,2004,13(24):3352-3354. 被引量:5
  • 2解好群,冯清仪,成仲,白萱.恶性弥漫性胸膜间皮瘤误诊分析[J].实用医技杂志,2005,12(01A):92-93. 被引量:2
  • 3李前伟.^(18)F-FDG PET在恶性胸膜间皮瘤中的应用[J].实用肿瘤杂志,2005,20(5):461-464. 被引量:4
  • 4杨雨,蒋明,罗德云.恶性胸膜间皮瘤临床治疗进展[J].华西医学,2005,20(1):177-178. 被引量:2
  • 5Peto J,Decarli A,La Vecchia C,et al.The European mesothelioma epidemic[J].Br J Cancer,1999(3-4),79:666-672.
  • 6Yoshio I,Yamaguchil M,Yokamoto T,et al.Multimodal treatment for respectable epithelial malignant pleural surgical[J].Oncology,2004,2(5):11.
  • 7Centers for Disease Control and Prevention (CDC).Malignant mesothelioma mortality-United State,1999-2005[J].Morb Mortal Wkly Rep.2009,58(15):393-396.
  • 8Bertazzi PA.Descriptive epidemiology of malignant mesotheliona[J].Med Lav,2005,96(4):287-303.
  • 9Testa JR,Carbone M,Hirvonen A,et al.Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma[J].Cancer Res,1998,58:4505-4509.
  • 10Bocchetta M,Di Resta I,Powers A,et al.Simian virus 40 and the human mesothelium[J].Proc Natl Acad Sci USA,2000,97:10214-10219.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部